Flagship Harbor Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $424K | Sell |
2,002
-10
| -0.5% | -$1.96K | 0.02% | 559 |
|
|
2026
Q1 | $394K | Hold |
2,012
| – | – | 0.02% | 531 |
|
|
2025
Q4 | $349K | Sell |
2,012
-266
| -12% | -$48.4K | 0.02% | 525 |
|
|
2025
Q3 | $434K | Buy |
2,278
+15
| +0.7% | +$2.66K | 0.02% | 532 |
|
|
2025
Q2 | $407K | Sell |
2,263
-11
| -0.5% | -$1.91K | 0.02% | 531 |
|
|
2025
Q1 | $385K | Sell |
2,274
-192
| -8% | -$31.5K | 0.02% | 507 |
|
|
2024
Q4 | $372K | Buy |
2,466
+2
| +0.1% | +$311 | 0.02% | 513 |
|
|
2024
Q3 | $383K | Buy |
2,464
+2
| +0.1% | +$299 | 0.02% | 487 |
|
|
2024
Q2 | $337K | Sell |
2,462
-67
| -3% | -$9.18K | 0.02% | 510 |
|
|
2024
Q1 | $337K | Sell |
2,529
-118
| -4% | -$15.3K | 0.02% | 489 |
|
|
2023
Q4 | $365K | Buy |
2,647
+4
| +0.2% | +$526 | 0.03% | 443 |
|
|
2023
Q3 | $322K | Sell |
2,643
-110
| -4% | -$14.7K | 0.03% | 446 |
|
|
2023
Q2 | $387K | Sell |
2,753
-6
| -0.2% | -$827 | 0.03% | 414 |
|
|
2023
Q1 | $390K | Buy |
2,759
+3
| +0.1% | +$429 | 0.04% | 408 |
|
|
2022
Q4 | $431K | Buy |
2,756
+3
| +0.1% | +$431 | 0.04% | 378 |
|
|
2022
Q3 | $338K | Sell |
2,753
-266
| -9% | -$35K | 0.04% | 403 |
|
|
2022
Q2 | $402K | Sell |
3,019
-30
| -1% | -$4.09K | 0.05% | 367 |
|
|
2022
Q1 | $417K | Sell |
3,049
-94
| -3% | -$13.1K | 0.04% | 396 |
|
|
2021
Q4 | $544K | Buy |
3,143
+171
| +6% | +$26K | 0.05% | 349 |
|
|
2021
Q3 | $392K | Hold |
2,972
| – | – | 0.04% | 401 |
|
|
2021
Q2 | $392K | Buy |
2,972
+129
| +5% | +$16.9K | 0.04% | 402 |
|
|
2021
Q1 | $365K | Buy |
2,843
+859
| +43% | +$106K | 0.04% | 426 |
|
|
2020
Q4 | $236K | Sell |
1,984
-182
| -8% | -$22.2K | 0.03% | 488 |
|
|
2020
Q3 | $248K | Sell |
2,166
-23
| -1% | -$2.72K | 0.03% | 416 |
|
|
2020
Q2 | $249K | Buy |
2,189
+73
| +3% | +$7.74K | 0.04% | 409 |
|
|
2020
Q1 | $170K | Buy |
2,116
+1,111
| +111% | +$115K | 0.03% | 425 |
|
|
2019
Q4 | $107K | Buy |
1,005
+1
| +0.1% | +$104 | 0.02% | 592 |
|
|
2019
Q3 | $107K | Hold |
1,004
| – | – | 0.02% | 560 |
|
|
2019
Q2 | $102K | Hold |
1,004
| – | – | 0.02% | 559 |
|
|
2019
Q1 | $90K | Sell |
1,004
-86
| -8% | -$7.45K | 0.02% | 588 |
|
|
2018
Q4 | $90K | Sell |
1,090
-56
| -5% | -$5.25K | 0.02% | 550 |
|
|
2018
Q3 | $124K | Sell |
1,146
-8
| -0.7% | -$877 | 0.02% | 533 |
|
|
2018
Q2 | $126K | Buy |
+1,154
| New | +$120K | 0.03% | 512 |
|
Other funds holding DGX
EIG
Flagship Harbor Advisors's DGX Position: Q2 2026 in Review
Flagship Harbor Advisors reduced its Quest Diagnostics (DGX) stake by 0.5% in Q2 2026, selling an estimated $1.96K and leaving 2,002 shares worth $424K. The position accounts for 0.02% of the portfolio, ranked #559.
Flagship Harbor Advisors first reported a position in DGX in Q2 2018 and has held it in 33 quarters since. The position peaked at $544K in Q4 2021. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Flagship Harbor Advisors held 2,002 shares of Quest Diagnostics worth $424K as of Q2 2026.
- Flagship Harbor Advisors sold 10 Quest Diagnostics shares in Q2 2026, an estimated $1.96K.
- Quest Diagnostics made up 0.02% of Flagship Harbor Advisors's portfolio in Q2 2026, its #559 holding.
- Flagship Harbor Advisors first reported a position in Quest Diagnostics in Q2 2018 and has held it in 33 quarters since.
- Flagship Harbor Advisors's Quest Diagnostics position peaked at $544K in Q4 2021.
- 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.